HHS Asks DC Court To Nix PhRMA's 340B Orphan Drug Suit
Law360, New York (January 28, 2015, 4:01 PM EST) -- The U.S. Department of Health and Human Services asked a D.C. federal court Tuesday to toss Pharmaceutical Research and Manufacturers of America's complaint challenging a department rule on discounting so-called orphan drugs in the 340B program, saying the interpretive rule wasn't subject to the court's review.
HHS issued the rule in July, setting out the agency's reading of an Affordable Care Act provision that, in some health care settings, exempts drugs from the discount requirement if they're designated for a rare disease. HHS has threatened to severely discipline drugmakers if they withhold discounts on the orphan drugs when they're used for relatively...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!